Docetaxel 20 Mg Injection Suppliers & Bulk Manufacturers

Available Forms: injection

Available Strengths: 20 mg/1 mL, 80 mg/4 mL,160 mg/8 mL

Reference Brands: Docefrez (EU)

Category: Oncology Cancer Care

Docetaxel is an intravenous chemotherapy drug used to treat cancers like breast cancer, NSCLC, prostate cancer, and more. Available in 20 mg/mL, 80 mg/4 mL, and 160 mg/8 mL vials, it is marketed as Taxotere® in both the US and EU, providing key B2B opportunities in oncology. Docetaxel 20 mg Injection is available in injection and strengths such as 20 mg/1 mL, 80 mg/4 mL,160 mg/8 mL. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Docetaxel 20 mg Injection is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Docetaxel 20 mg Injection can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description:

Docetaxel is an intravenous chemotherapy agent used to treat a variety of cancers, including breast cancer, non-small cell lung cancer (NSCLC), prostate cancer, and head and neck cancers. As a taxane, it works by inhibiting cell division, effectively preventing cancer cell proliferation. Available in 20 mg/mL, 80 mg/4 mL, and 160 mg/8 mL vial strengths, Docetaxel is marketed under the brand name Taxotere® in both the US and EU. The drug offers significant B2B opportunities for pharmaceutical companies targeting oncology treatments in these regions.